A study to compare how the body absorbs empagliflozin tablets in healthy individuals.
- Substances:Empagliflozin
Portugal- Participants:18–64 years · Healthy volunteers
- Substances:Empagliflozin
- Sponsor:Tecnimede-Sociedade Tecnico-Medicinal S.A.
Rare diseases
Investigational molecules
Locations
Back to Portugal637 clinical trials in Santa Maria Da Feira, Portugal. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PortugalEnsaios-Clinicos.pt(opens in a new tab)
Portugal
Portugal
PortugalEvaluation of Safety and Efficacy of Zilovertamab Vedotin and Nemtabrutinib in Aggressive and Indolent B-cell Malignancies
Portugal
PortugalRelative Bioavailability of LY03010 versus Paliperidone Palmitate (with Risperidone background) in Healthy Volunteers for Schizophrenia
PortugalA study to compare the absorption of eltrombopag olamine in healthy volunteers to ensure the tablets work the same way for patients with thrombocytopenia or aplastic anemia.
PortugalA study to compare the absorption of testosterone transdermal gel in healthy female subjects
PortugalA study to evaluate how cytisinicline works in patients with nicotine addiction and kidney problems or those undergoing dialysis
PortugalA Study Testing the Safety and How Well GTX-102 Works in Adults and Children with Angelman Syndrome
PortugalStudy of romiplostim for treating low platelet counts caused by chemotherapy in adults with non-small cell lung cancer, ovarian cancer, or breast cancer
PortugalA Study Comparing Eltrombopag Tablets in Healthy Volunteers to Test if Two Forms of the Medicine Work the Same Way in the Body After Taking with Food
PortugalThe busiest research cities in the country
What the registry says about research in the country
Ongoing research evaluating novel treatments for multiple sclerosis and epilepsy, with studies focusing on both relapsing and progressive forms of MS, as well as various types of seizure disorders.
Multiple trials testing new compounds like tolebrutinib and fenebrutinib for long-term disease management.
Studies focusing on preventing cardiovascular events and managing atherosclerotic disease, with particular attention to high-risk patients and post-stroke care.
Innovative therapies being tested to reduce major adverse cardiovascular events and improve patient outcomes.
Research targeting inflammatory bowel diseases, including studies on Crohn's Disease and ulcerative colitis, testing new therapeutic approaches.
Evaluating combination therapies and novel compounds for moderate to severe disease states.
Tell us about your condition – we search every trial in Europe and connect you with the right site.